Blanket Purchase Agreement GS35F0234W-HHSF223201810001B

The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Collabralink Technologies, Incorporated for CDER WORKFLOW MANAGEMENT PROGRAM (WFM) services. The single award contract has a potential value of $140 million and a period of performance through April 2026. The BPA aims to procure workflow management services to support the Center for Drug Evaluation and Research. Specifically, the prime contractor will deliver solutions for...

The Department of Health and Human Services Food and Drug Administration awarded a single award Blanket Purchase Agreement to Rei Systems, Inc. under the Multiple Award Schedule contracting vehicle. With a potential value of $140 million and a period of performance through April 2026, this BPA aims to procure CDER Workflow Management Program services. The BPA will facilitate delivery of products and services to support the Center for Drug Evaluation and Research's workflow management...

The U.S. Food and Drug Administration (FDA) has awarded a $99 million Blanket Purchase Agreement (BPA) to Deloitte Consulting LLP, a leading management and technology consulting firm, for the Center for Drug Evaluation and Research (CDER) Office of Business Informatics (OBI) Drug Supply Chain program. Under this BPA, Deloitte will provide a range of services, including data curation, IT modernization, data analytics, and expert consulting to support the FDA's efforts to implement legislative...

The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Ignyte Group Inc. as a single-award contract under the Multiple Award Schedule. With a potential value of $140 million and a period of performance through April 2026, the BPA aims to procure CDER Workflow Management Program services. The CDER WFM BPA will provide services to support the Center for Drug Evaluation and Research's workflow management initiatives. This includes...

The Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Technology Solutions Provider, Inc. as a single-award contract under the Multiple Award Schedule. With a potential value of $140 million, the BPA aims to procure workflow management services for the FDA's Center for Drug Evaluation and Research over a five-year period of performance ending in April 2026. The BPA will facilitate task orders related to the CDER...

The Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services, to provide Regulatory Review Support Services. The master BPA has a ceiling value of $163,000,000 and a period of performance through March 2025. Under this BPA, the FDA has issued multiple task orders to Booz Allen Hamilton for services related to the Advanced Information Retrieval Research System (AIRRS),...

This BPA was originally awarded by the General Services Administration (GSA) Federal Systems Integration and Management Center (FEDSIM) to Platinum Solutions Inc. and later novated to SRA International, Inc. (now General Dynamics Information Technology, Inc. (GDIT), a division of CSRA LLC). The BPA provides operations, maintenance, development, and modernization services for the Food and Drug Administration's (FDA) Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) program....

This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency within the Department of Health and Human Services, to Deloitte Consulting LLP, a leading management and technology consulting firm. The BPA, valued at $30,813,738.04, covers a range of drug labeling initiative services over a 5-year period through September 2027. The contract includes multiple individual task orders for firm fixed-price services related to updating labeling for...

This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Accenture Federal Services LLC, a global professional services company. The BPA, valued at up to $90 million, is for the provision of scientific, program management, and informatics governance modernization support services to the FDA's Center for Drug Evaluation and Research (CDER). Specific task orders issued under the BPA include a $13.4 million firm fixed-price...

This Blanket Purchase Agreement (BPA) contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to International Business Machines Corporation (IBM) as the prime contractor. The contract has a ceiling value of $163,000,000 and a performance period through March 29, 2025. Under this BPA, IBM will provide a range of regulatory review support services to the FDA, including data management, analysis, standards...